Are there specific types/brands of drug-eluting stent you prefer that perform well in terms of lower ISR rates or ones that are better for patients with high bleeding risk?

That is a great question.

All of the currently available drug-eluting stents are very safe, and you can now get away with just one month of dual antiplatelet therapy (DAPT) in a patient with high bleeding risk. There is more and more evidence of using clopidogrel only monotherapy instead of using DA...

ISR, often identified as TLR in studies, has a low single-digit incidence (1-2% per year) with newer generation DES. Ultrathin strut (60-70 um) and durable polymer DES seem intuitively the best options to minimize ISR/TLR, but a network meta-analysis of almost 50k patients in RCTs suggested that all...